home / stock / mxct / mxct articles

MXCT Articles, MaxCyte Inc. - From 03/04/24

Stock Information
Company Name: MaxCyte Inc.
Stock Symbol: MXCT
Market: NASDAQ
Website: maxcyte.com
Menu
MXCT MXCT Quote MXCT Short MXCT News MXCT Articles MXCT Message Board
Get MXCT Alerts

News, Short Squeeze, Breakout and More Instantly...
MaxCyte Initiates Full Year 2024 Guidance and Reaffirms 2023 Preliminary Results | Benzinga

ROCKVILLE, Md., March 04, 2024 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (NASDAQ:MXCT, LSE: MXCT)), a leading, cell-engineering focused company providi...
MaxCyte to Report Fourth Quarter and Full Year 2023 Financial Results on March 12, 2024 and Participate in Upcoming Investor Conferences | Benzinga

ROCKVILLE, Md., Feb. 09, 2024 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (NASDAQ:MXCT, LSE: MXCT)), a leading, cell-engineering focused company providin...

Acuity Brands Posts Upbeat Earnings, Joins Accolade, Urban Outfitters And Other Big Stocks Moving Higher On Tuesday | Benzinga

U.S. stocks traded lower, with the Dow Jones index falling over 250 points on Tuesday. Shares of Acuity Brands, Inc. (NYSE: AYI) rose sharply Tuesd...

Why Cell Engineering Company MaxCyte Shares Are Up Today | Benzinga

MaxCyte Inc (NASDAQ: MXCT) shares are trading higher by over 9% after the company disclosed strong preliminary Q4 and full-year 2023 reve...
MaxCyte Announces Preliminary Unaudited Fourth Quarter and Full Year 2023 Financial Results | Benzinga

ROCKVILLE, Md., Jan. 08, 2024 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (NASDAQ:MXCT, LSE: MXCT)), a leading, cell-engineering focused company providin...

MaxCyte Confirms Appointment of Maher Masoud as President, Chief Executive Officer and Director | Benzinga

ROCKVILLE, Md., Jan. 01, 2024 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (NASDAQ:MXCT, LSE: MXCT)), a leading, cell-engineering focused company providin...

MaxCyte Announces CEO Transition and Updates Revenue Guidance for 2023 | Benzinga

Doug Doerfler, President and CEO, to Retire Effective December 31, 2023; will continue to serve as an advisor to MaxCyte Maher Masoud, EVP, Head o...
MaxCyte to Participate in Two Upcoming Investor Conferences | Benzinga

ROCKVILLE, Md., Nov. 06, 2023 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (NASDAQ:MXCT, LSE: MXCT)), a leading, cell-engineering focused company providin...

Cell Engineering MaxCyte Faces Challenge, Analysts Express Concerns Over Near-Term Prospects Amid Revenue Decline | Benzinga

MaxCyte Inc (NASDAQ: MXCT) shares plummeted after the company released preliminary Q3 revenue of $7.8 million – 8.0 million, a Y/Y decre...

Crude Oil Down 2%; ConAgra Brands Earnings Top Views | Benzinga

U.S. stocks traded slightly lower toward the end of trading, with the Dow Jones index falling around 40 points on Thursday. The Dow traded down 0.1...
Previous 10 Next 10